Cannabis Teratology Explains Current Patterns of Coloradan Congenital Defects: The Contribution of Increased Cannabinoid Exposure to Rising Teratological Trends

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Rising Delta 9-tetrahydrocannabinol concentrations in modern cannabis invites investigation of the teratological implications of prenatal cannabis exposure. Data from Colorado Responds to Children with Special Needs (CRCSN), National Survey of Drug Use and Health, and Drug Enforcement Agency was analyzed. Seven, 40, and 2 defects were rising, flat, and falling, respectively, and 10/12 summary indices rose. Atrial septal defect, spina bifida, microcephalus, Down's syndrome, ventricular septal defect, and patent ductus arteriosus rose, and along with central nervous system, cardiovascular, genitourinary, respiratory, chromosomal, and musculoskeletal defects rose 5 to 37 times faster than the birth rate (3.3%) to generate an excess of 11 753 (22%) major anomalies. Cannabis was the only drug whose use grew from 2000 to 2014 while pain relievers, cocaine, alcohol, and tobacco did not. The correlation of cannabis use with major defects in 2014 (2019 dataset) was R = .77, P = .0011. Multiple cannabinoids were linked with summary measures of congenital anomalies and were robust to multivariate adjustment.

Original languageEnglish
Article number0009922819861281
Pages (from-to)1085–1123
Number of pages39
JournalClinical Pediatrics
Volume58
Issue number10
DOIs
Publication statusPublished - Sep 2019

Cite this

@article{f6e013e52ff346ef859027485d8c796e,
title = "Cannabis Teratology Explains Current Patterns of Coloradan Congenital Defects: The Contribution of Increased Cannabinoid Exposure to Rising Teratological Trends",
abstract = "Rising Delta 9-tetrahydrocannabinol concentrations in modern cannabis invites investigation of the teratological implications of prenatal cannabis exposure. Data from Colorado Responds to Children with Special Needs (CRCSN), National Survey of Drug Use and Health, and Drug Enforcement Agency was analyzed. Seven, 40, and 2 defects were rising, flat, and falling, respectively, and 10/12 summary indices rose. Atrial septal defect, spina bifida, microcephalus, Down's syndrome, ventricular septal defect, and patent ductus arteriosus rose, and along with central nervous system, cardiovascular, genitourinary, respiratory, chromosomal, and musculoskeletal defects rose 5 to 37 times faster than the birth rate (3.3{\%}) to generate an excess of 11 753 (22{\%}) major anomalies. Cannabis was the only drug whose use grew from 2000 to 2014 while pain relievers, cocaine, alcohol, and tobacco did not. The correlation of cannabis use with major defects in 2014 (2019 dataset) was R = .77, P = .0011. Multiple cannabinoids were linked with summary measures of congenital anomalies and were robust to multivariate adjustment.",
keywords = "delta9-tetrahydrocannabininol, cannabidiol, epigenetic genotoxicity, congenital teratogenicity, congenital, cardiovascular malformations, ILLICIT DRUG-USE, MARIJUANA USE, PRENATAL MARIJUANA, BIRTH-DEFECTS, RISK, NEUROGENESIS, ASSOCIATION, POTENCY, ABUSE, BETA",
author = "Reece, {Albert Stuart} and Hulse, {Gary Kenneth}",
year = "2019",
month = "9",
doi = "10.1177/0009922819861281",
language = "English",
volume = "58",
pages = "1085–1123",
journal = "Clinical Pediatrics",
issn = "0009-9228",
publisher = "SAGE Publications Ltd",
number = "10",

}

TY - JOUR

T1 - Cannabis Teratology Explains Current Patterns of Coloradan Congenital Defects

T2 - The Contribution of Increased Cannabinoid Exposure to Rising Teratological Trends

AU - Reece, Albert Stuart

AU - Hulse, Gary Kenneth

PY - 2019/9

Y1 - 2019/9

N2 - Rising Delta 9-tetrahydrocannabinol concentrations in modern cannabis invites investigation of the teratological implications of prenatal cannabis exposure. Data from Colorado Responds to Children with Special Needs (CRCSN), National Survey of Drug Use and Health, and Drug Enforcement Agency was analyzed. Seven, 40, and 2 defects were rising, flat, and falling, respectively, and 10/12 summary indices rose. Atrial septal defect, spina bifida, microcephalus, Down's syndrome, ventricular septal defect, and patent ductus arteriosus rose, and along with central nervous system, cardiovascular, genitourinary, respiratory, chromosomal, and musculoskeletal defects rose 5 to 37 times faster than the birth rate (3.3%) to generate an excess of 11 753 (22%) major anomalies. Cannabis was the only drug whose use grew from 2000 to 2014 while pain relievers, cocaine, alcohol, and tobacco did not. The correlation of cannabis use with major defects in 2014 (2019 dataset) was R = .77, P = .0011. Multiple cannabinoids were linked with summary measures of congenital anomalies and were robust to multivariate adjustment.

AB - Rising Delta 9-tetrahydrocannabinol concentrations in modern cannabis invites investigation of the teratological implications of prenatal cannabis exposure. Data from Colorado Responds to Children with Special Needs (CRCSN), National Survey of Drug Use and Health, and Drug Enforcement Agency was analyzed. Seven, 40, and 2 defects were rising, flat, and falling, respectively, and 10/12 summary indices rose. Atrial septal defect, spina bifida, microcephalus, Down's syndrome, ventricular septal defect, and patent ductus arteriosus rose, and along with central nervous system, cardiovascular, genitourinary, respiratory, chromosomal, and musculoskeletal defects rose 5 to 37 times faster than the birth rate (3.3%) to generate an excess of 11 753 (22%) major anomalies. Cannabis was the only drug whose use grew from 2000 to 2014 while pain relievers, cocaine, alcohol, and tobacco did not. The correlation of cannabis use with major defects in 2014 (2019 dataset) was R = .77, P = .0011. Multiple cannabinoids were linked with summary measures of congenital anomalies and were robust to multivariate adjustment.

KW - delta9-tetrahydrocannabininol

KW - cannabidiol

KW - epigenetic genotoxicity

KW - congenital teratogenicity

KW - congenital

KW - cardiovascular malformations

KW - ILLICIT DRUG-USE

KW - MARIJUANA USE

KW - PRENATAL MARIJUANA

KW - BIRTH-DEFECTS

KW - RISK

KW - NEUROGENESIS

KW - ASSOCIATION

KW - POTENCY

KW - ABUSE

KW - BETA

U2 - 10.1177/0009922819861281

DO - 10.1177/0009922819861281

M3 - Article

VL - 58

SP - 1085

EP - 1123

JO - Clinical Pediatrics

JF - Clinical Pediatrics

SN - 0009-9228

IS - 10

M1 - 0009922819861281

ER -